About ADC Therapeutics
Innovating Science. Inspiring Hope.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Lausanne, Vaud, Switzerland
- Founded
- 2011
- Company type
- Public Company
ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs).
Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. We are a pioneer in the ADC field with specialized capabilities unique to ADCs from clinical to manufacturing and commercialization with a proven track record that includes an approved and marketed product.
Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics is leveraging its expertise to advance IND-enabling activities for a next-generation PSMA-targeting ADC.
Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer.
For more information, please visit https://www.adctherapeutics.com/.
Company locations
Lausanne, Vaud, Switzerland, CH
430 Mountain Avenue, Suite #404, New Providence, NJ 94404, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 23,849
- People linked to this company
- 261
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.